ReviewCurrent atherosclerosis reports2023

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial.

Walter Oliver et al.PubMed ↗Publisher ↗

No numbers read from the abstract.